MEDI 75-Design and synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived inhibitors of CC chemokine receptor 2 (CCR2)

被引：0

作者：

Xiao, Zili ^{[1
]}

Delucca, George V. ^{[1
]}

Cherney, Robert J. ^{[1
]}

Shi, Qing ^{[1
]}

Mo, Ruowei ^{[1
]}

Santella, Joseph B. ^{[1
]}

Tebben, Andrew J. ^{[2
]}

Cvijic, Mary Ellen ^{[3
]}

Zhao, Qihong ^{[4
]}

Barrish, Joel C. ^{[1
]}

Carter, Percy H. ^{[1
]}

Yang, Michael G. ^{[1
]}

机构：

[1] Bristol Myers Squibb Res & Dev, Discovery Chem, Princeton, NJ 08543 USA

[2] Bristol Myers Squibb Co, Comp Assisted Drug Design, Princeton, NJ 08543 USA

[3] Bristol Myers Squibb Co, Lead Evaluat, Res & Dev, Princeton, NJ 08543 USA

[4] Bristol Myers Squibb Co, Immunol Biol, Res & Dev, Princeton, NJ 08543 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

75-MEDI

引用

页数：1

共 50 条

[41] CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD
Falk, Mads Kruger
Singh, Amardeep
Faber, Carsten
Nissen, Mogens Holst
Hviid, Thomas
Sorensen, Torben Lykke
PLOS ONE, 2014, 9 (12):
[42] Pharmacophore Model-based Design and Synthesis of New Structure Small Molecule CCR2 Inhibitors
Qin Lihuai
Li Xiaoguang
Wang Zhilong
Yao Wenbo
Wang Hui
Xie Xin
Long Yaqiu
ACTA CHIMICA SINICA, 2015, 73 (07) : 679 - 684
[43] The Chemokine Receptor CCR2 and Interleukin 23 derived from Antigen Presenting Cells are Essential for Primary Biliary Cholangitis Progression
Reuveni, Debby
Leung, Patrick S.
Shibolet, Oren
Gershwin, M. Eric
Zigmond, Ehud
HEPATOLOGY, 2016, 64 : 524A - 524A
[44] MEDI 376-Synthesis and biological evaluation of 2,4-diaminoquinazoline derivatives and related compounds as novel CC chemokine receptor 4 (CCR4) antagonists
Kawano, Noriyuki
Kontani, Toru
Masuda, Naoyuki
Koganemaru, Yohei
Hamaguchi, Wataru
Kaizawa, Hiroyuki
Kato, Koji
Igarashi, Susumu
Nagata, Hiroshi
Inami, Hiroshi
Terasaka, Tadashi
Ishikawa, Noriko
Yokoyama, Kazuhiro
Ogino, Shinichi
Kondo, Mitsuhiro
Takeuchi, Makoto
Ohta, Mitsuaki
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[45] Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Naert, Gaelle
Rivest, Serge
MOLECULAR MEDICINE, 2012, 18 (02) : 297 - 313
[46] CC Chemokine Receptor 2 (CCR2) in ANCA Disease: Different Roles in Glomerulonephritis vs. Lung Granulomatosis in MPO-ANCA Induced Mouse Model
Hu, Peiqi
Xiao, Hong
Alba, Marco A.
Gou, Shen-Ju
Hu, Yanglin
Falk, Ronald
Jennette, J. Charles
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 482 - 482
[47] Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer’s Disease
Gaëlle Naert
Serge Rivest
Molecular Medicine, 2012, 18 : 297 - 313
[48] A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma
Mendez-Enriquez, E.
Medina-Tamayo, J.
Soldevila, G.
Fortoul, T. I.
Anton, B.
Flores-Romo, L.
Garcia-Zepeda, E. A.
INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 20 (01) : 1 - 11
[49] Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis
Bayley, JP
Baggen, JM
von der Pouw-Kraan, T
Crusius, JBA
Huizinga, TWJ
Verweij, CL
TISSUE ANTIGENS, 2003, 62 (02): : 170 - 174
[50] Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists
Lim, Jee Woong
Oh, Youna
Kim, Jong-Hoon
Oak, Min-Ho
Na, Yongho
Lee, Jung-Ok
Lee, Seung-Woo
Cho, Heeyeong
Park, Woo-Kyu
Choi, Gildon
Kang, Jongmin
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2099 - 2102

← 1 2 3 4 5 →